REMEDY Raises Series A Led by L Catterton to Modernize Dermatologist-Developed Skincare
Minority investment will support clinical research, product innovation, team expansion, and continued growth across DTC, Amazon, and Target LOS ANGELES — Remedy Science (“REMEDY”), the dermatologist-developed, education-first skincare brand translating clinical expertise into accessible, high-performance products, today announced the closing of its Series A funding round led by L Catterton, the largest global consumer-focused investment […]
Original Source
Read the full article at Financialpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.